// App-Quantinova.ai

OC 34.1 : Bleeding in Patients with Genitourinary Cancer compared to Non-Genitourinary Cancer Treated with Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism

Researchers

Presenter

  • T. Lang

Principal Investigators

  • D. Vlazny

  • D. Houghton

  • A. Casanegra

  • D. Froehling

  • D. Hodge

  • L. Peterson

  • R. McBane

  • W. Wysokinski

Medical Centers

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

  • Mayo Clinic, Jacksonville, Jacksonville, Florida, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT03504007

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved